John H Fetting

Associate Professor

1973 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where John H Fetting is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Adjuvant Chemotherapy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Anticipatory Vomiting Medicine & Life Sciences
Nausea Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1973 2019

Pathogenic Germline Variants in Patients with Metastatic Breast Cancer

Stuttgen, K., Croessmann, S., Fetting, J. H., Stearns, V., Nunes, R., Connolly, R. M. & Park, B. H., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalLetter

Breast Neoplasms

Sharing in care: engaging care partners in the care and communication of breast cancer patients

Wolff, J., Aufill, J., Echavarria, D., Heughan, J. A. A., Lee, K. T., Connolly, R., Fetting, J. H., Jelovac, D., Papathakis, K., Riley, C., Stearns, V., Thorner, E., Zafman, N., Levy, H. P., Dy, S. E. & Wolff, A. C., Jan 1 2019, In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

Communication
Breast Neoplasms
Checklist
Patient Care
Neoplasms

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Santa-Maria, C., Bardia, A., Blackford, A. L., Snyder, C., Connolly, R., Fetting, J. H., Hayes, D. F., Jeter, S. C., Miller, R. S., Nguyen, A., Quinlan, K., Rosner, G., Slater, S., Storniolo, A. M., Wolff, A. C., Zorzi, J., Henry, N. L. & Stearns, V., May 11 2018, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-9 9 p.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Aromatase Inhibitors
exemestane
Pharmacogenetics

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer

Litvak, A., Batukbhai, B., Russell, S. D., Tsai, H. L., Rosner, G., Jeter, S. C., Armstrong, D. K., Emens, L. A., Fetting, J. H., Wolff, A. C., Silhy, R., Stearns, V. & Connolly, R., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Confidence Intervals
Stroke Volume
Incidence

Combination epigenetic therapy in advanced breast cancer with 5-azacitidine and entinostat: A phase II national cancer institute/stand up to cancer study

Connolly, R., Li, H., Jankowitz, R. C., Zhang, Z., Rudek-Renaut, M., Jeter, S. C., Slater, S. A., Powers, P., Wolff, A. C., Fetting, J. H., Brufsky, A., Piekarz, R., Ahuja, N., Laird, P. W., Shen, H., Weisenberger, D. J., Cope, L., Herman, J. G., Somlo, G., Garcia, A. A. & 5 others, Jones, P. A., Baylin, S. B., Davidson, N. E., Zahnow, C. & Stearns, V., Jun 1 2017, In : Clinical Cancer Research. 23, 11, p. 2691-2701 11 p.

Research output: Contribution to journalArticle

Azacitidine
National Cancer Institute (U.S.)
Epigenomics
Breast Neoplasms
Triple Negative Breast Neoplasms